PMID- 26758954 OWN - NLM STAT- MEDLINE DCOM- 20171030 LR - 20191113 IS - 1874-4702 (Electronic) IS - 1874-4672 (Linking) VI - 9 IP - 4 DP - 2016 TI - Role of Hexokinase and VDAC in Neurological Disorders. PG - 320-331 AB - Several neurological diseases such as bipolar disorders and schizophrenia are linked to impaired brain energy metabolism. A key feature of brain bioenergetics is hexokinase (HK) binding to the outer mitochondrial membrane through the voltage dependent anion channel (VDAC). This has metabolic consequences, with phosphorylation of glucose by mitochondrially bound hexokinase being closely coupled to production of substrate ATP by intramitochondrial oxidative phosphorylation. Additionally, binding of HK to mitochondria inhibits Bax-induced cytochrome c release and apoptosis. Moreover VDAC1 expression level is elevated in cerebellum of patients with Down s syndrome, while in Alzheimer s disease, VDAC1 levels are decreased in frontal cortex and VDAC2 elevated in temporal cortex. Thus, understanding the roles of VDAC and HK, either separate or interacting in brain, provides new opportunities and challenges to elucidate pathophysiological mechanisms for future therapeutic strategies. FAU - Rosa, Jose Cesar AU - Rosa JC FAU - Cesar, Marcelo de Cerqueira AU - Cesar MC AD - Laboratory of Neuroscience and Proteomics, School of Animal Science and Food Engineering, University of Sao Paulo, Av. Duque de Caxias Norte 225, 13635-900, Pirassununga, SP, Brazil. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review PL - United Arab Emirates TA - Curr Mol Pharmacol JT - Current molecular pharmacology JID - 101467997 RN - 0 (Voltage-Dependent Anion Channels) RN - EC 2.7.1.1 (Hexokinase) SB - IM MH - Animals MH - Brain/metabolism/pathology MH - Hexokinase/*metabolism MH - Humans MH - Mitochondria/metabolism MH - Nervous System Diseases/*metabolism MH - Neurons/metabolism/pathology MH - Voltage-Dependent Anion Channels/*metabolism EDAT- 2016/01/14 06:00 MHDA- 2017/10/31 06:00 CRDT- 2016/01/14 06:00 PHST- 2015/06/12 00:00 [received] PHST- 2015/08/25 00:00 [revised] PHST- 2015/01/06 00:00 [accepted] PHST- 2016/01/14 06:00 [pubmed] PHST- 2017/10/31 06:00 [medline] PHST- 2016/01/14 06:00 [entrez] AID - CMP-EPUB-73024 [pii] AID - 10.2174/1874467209666160112123036 [doi] PST - ppublish SO - Curr Mol Pharmacol. 2016;9(4):320-331. doi: 10.2174/1874467209666160112123036.